ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $369,477 | +122.6% | 15,427 | +30.8% | 0.01% | +66.7% |
| Q2 2022 | $166,000 | -0.6% | 11,793 | +17.5% | 0.00% | +200.0% |
| Q3 2021 | $167,000 | -32.4% | 10,036 | +67.4% | 0.00% | -80.0% |
| Q3 2020 | $247,000 | -86.3% | 5,996 | -83.8% | 0.01% | -91.5% |
| Q2 2020 | $1,799,000 | +3.6% | 37,117 | -8.6% | 0.06% | +84.4% |
| Q4 2019 | $1,737,000 | +239.9% | 40,605 | +186.0% | 0.03% | +128.6% |
| Q3 2019 | $511,000 | -76.5% | 14,200 | -82.5% | 0.01% | -77.0% |
| Q2 2019 | $2,176,000 | +1235.0% | 81,374 | +660.9% | 0.06% | +510.0% |
| Q2 2018 | $163,000 | -53.0% | 10,695 | +16.0% | 0.01% | -64.3% |
| Q3 2017 | $347,000 | -48.6% | 9,217 | -53.1% | 0.03% | -55.6% |
| Q1 2017 | $675,000 | – | 19,639 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |